Smaller peptides used in skincare, like GHK-Cu, are applied topically, but topical absorption of larger injected peptides is unreliable
Research protocols for bone healing applications have typically used dosages in the range of 200 to 300 micrograms administered subcutaneously, though the specific BPC-157 dosing protocols vary depending on the study design and objectives
Many patients with complex chronic illnesses develop a phenomenon known as Toxicant-Induced Loss of Tolerance (TILT), where they become hypersensitive to chemicals, fragrances, and foods that never previously bothered them
One of the most interesting developments I continue to observe is the growing attention toward copper peptides, particularly GHK-Cu
Their messaging repeatedly emphasizes products that work, and from an industry standpoint, I think that is a meaningful phrase
Supports barrier repair and moisture retention